No Data
No Data
Guobang Pharmaceutical (605507.SH): Cumulative repurchase of 1.10% of shares.
On July 1st, Gelon Hui reported that Guobang Medicine (605507.SH) has repurchased a total of 6,127,000 shares through concentrated bidding trading method as of June 30, 2024. The repurchased shares account for 1.10% of the company's total share capital, with the highest transaction price of 18.66 CNY/share and the lowest transaction price of 13.05 CNY/share. The total amount paid was 99,515,878.00 CNY (excluding transaction costs).
Guobang Pharmaceutical (605507.SH) plans to launch the first phase of employee shareholding plan.
On June 27th, Gelunhui, Guobang Medicine (605507.SH) announced the first phase of the employee stock ownership plan. The initial total amount of funds raised for this employee stock ownership plan will not exceed 125 million yuan, of which the employee self-raised funds will not exceed 125 million yuan, and the specific amount will be determined according to the actual contribution payment. The total number of stocks involved in this employee stock ownership plan does not exceed 10% of the total share capital of the company, and the total number of stocks corresponding to the share of any employee stock ownership plan held by any holder does not exceed 1% of the total share capital of the company. The total number of people does not exceed 260, including directors who participate in the stock ownership plan.
Guobang Pharma Ltd.'s (SHSE:605507) Share Price Is Matching Sentiment Around Its Earnings
When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 29x, you may consider Guobang Pharma Ltd. (SHSE:605507) as an attractive investment with its 15.1x P/E ratio.
Guobang Pharmaceutical (605507.SH) will distribute a dividend of 0.30153 yuan per share in 2023, with a record date of June 13.
Guobang Pharmaceutical (605507.SH) has announced that the company will distribute annual equity dividends in 2023, with a distribution of X yuan per share ...
Guobang Pharmaceutical (605507.SH): A total cost of 995.15,900 yuan to buy back 1.1% of the shares
Gelonghui, May 31, 丨 Guobang Pharmaceutical (605507.SH) announced that as of May 31, 2024, the company had repurchased a total of 6,127,000 shares through centralized bidding transactions. The repurchased shares accounted for 1.10% of the company's total share capital. The highest transaction price was 18.66 yuan/share, the lowest price was 13.05 yuan/share, and the total amount paid was 99,515,878.00 yuan (not including transaction fees).
Guobang Pharmaceutical (605507.SH): A total cost of 94.99 million yuan to buy back 1.05% of the shares
Gelonghui, May 23丨Guobang Pharmaceutical (605507.SH) announced that as of May 22, 2024, the company had repurchased 5,875,200 shares through centralized bidding transactions. The repurchased shares accounted for 1.05% of the company's total share capital. The highest price of the repurchase transaction was 18.66 yuan/share, the lowest price was 13.05 yuan/share, and the total amount of capital paid was 94,990,928 yuan (not including transaction fees).
No Data